by Alexandrea Macpherson | Jan 11, 2024 | NEWS, OUTPUTS
PREDICT-Meso Co-I Daniel J. Murphy co-authoured a paper accepted for publication in Cell Death and Disease, with Olivier E. Pardo and Yakinthi Chrisochoidou at Imperial. This work was carried out as part of WP4- Target Drug Validation Abstract Mesothelioma is an...
by Alexandrea Macpherson | Aug 10, 2023 | NEWS, OUTPUTS
Abstract Objectives: To assess key elements of the design for Meso-ORIGINS (Mesothelioma Observational study of RIsk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy), an ambitious, UK-wide, prospective study that...
by Alexandrea Macpherson | Jul 11, 2023 | NEWS, OUTPUTS
Congratulations to Pooyeh Farahmand of the Murphy lab in Glasgow and collaborators (full authors list below) on publication of their paper ‘Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma’ in Frontiers in Toxicology...
by Alexandrea Macpherson | Jul 11, 2023 | NEWS, OUTPUTS
PREDICT-Meso is committed to training the next generation of mesothelioma researchers, and to share knowledge and best practice within the Network and beyond. To fulfill this commitment, over the next few years PREDICT-Meso will run a series of training schools...
by Alexandrea Macpherson | Jul 11, 2023 | NEWS, OUTPUTS
The 16th international Mesothelioma interest group (iMig) conference happened last month (Jun26-28) in Lille, France. https://imig2023.org/ It was a energetic and exciting conference and PREDICT-Meso was very busy- see below for more detail: PREDICT-Meso lead, Prof...
by Alexandrea Macpherson | Apr 4, 2023 | NEWS, OUTPUTS
The international Mesothelioma interest Group (iMig) @imig2023 are hosting their 16th international conference in June in Lille, France. PREDICT-Meso Network members in Glasgow submitted 6 abstracts and we are delighted to announce that all were accepted- 4 poster...
